Tenaya Therapeutics' finances are precarious with significan...

Tenaya Therapeutics' finances are precarious with significant cash burn relative to its market cap. Despite decreased cash burn, the absence of revenue and huge spending amplify the risk profile. The company's abilities to secure more funding are in doubt.